MEDIFAST INC Income Statement
MED|13 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
MEDIFAST INC reported $386M in revenue and $19M in net loss for FY2025. Revenue has grown at a 6.0% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.08 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $385.8M | $602.5M | $1.1B | $501.0M | $301.6M | $274.5M | $272.8M | $285.3M | $324.1M | $318.6M | $298.2M | $257.6M | $169.7M |
| Cost of Revenue | $110.6M | $157.8M | $296.2M | $121.1M | $73.8M | $68.9M | $71.5M | $76.1M | $83.5M | $82.7M | $73.7M | $65.1M | $45.4M |
| Gross Profit | $275.2M | $444.6M | $775.9M | $379.9M | $227.8M | $205.7M | $201.3M | $209.2M | $240.6M | $235.9M | $224.5M | $192.5M | $124.4M |
| SG&A Expense | $289.4M | $441.7M | $649.4M | $310.8M | $188.2M | $178.8M | $172.6M | $179.0M | $202.2M | $208.8M | $197.1M | $160.8M | $105.9M |
| R&D Expense | $4.3M | $4.6M | $4.6M | $2.2M | $1.5M | $2.0M | $1.8M | $1.3M | - | - | - | - | - |
| Operating Income | -$14.2M | $2.9M | $126.4M | $69.1M | $39.6M | $26.9M | $28.7M | $30.2M | $38.4M | $27.1M | $27.4M | $31.6M | $18.5M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | $89.0K | $102.0K | $145.0K |
| Income Tax | $13.0M | $1.7M | $29.4M | $14.8M | $12.6M | $9.3M | $10.1M | $10.7M | $11.9M | $9.9M | $9.1M | $12.1M | $7.1M |
| Net Income | -$18.7M | $2.1M | $99.4M | $55.8M | $27.7M | $17.8M | $20.1M | $13.2M | $24.0M | $15.9M | $18.5M | $19.6M | $11.4M |
| EPS (Basic) | $9.13 | $12.82 | $14.01 | $4.67 | $2.32 | $1.51 | $1.68 | $1.04 | $1.74 | $1.16 | $1.33 | $1.39 | $0.84 |
| EPS (Diluted) | $9.10 | $12.73 | $13.89 | $4.62 | $2.29 | $1.49 | $1.66 | $1.03 | $1.73 | $1.16 | $1.31 | $1.35 | $0.77 |
| Shares Outstanding | 10.9M | 10.9M | 10.9M | 11.8M | 11.9M | 12.0M | 11.9M | 11.8M | 12.1M | 13.1M | 13.8M | 13.6M | 15.4M |
| Gross Margin | 71.3% | 73.8% | 72.4% | 75.8% | 75.5% | 74.9% | 73.8% | 73.3% | 74.2% | 74.1% | 75.3% | 74.7% | 73.3% |
| Operating Margin | -3.7% | 0.5% | 11.8% | 13.8% | 13.1% | 9.8% | 10.5% | 10.6% | 11.8% | 8.5% | 9.2% | 12.3% | 10.9% |
| Profit Margin | -4.8% | 0.4% | 9.3% | 11.1% | 9.2% | 6.5% | 7.3% | 4.6% | 7.4% | 5.0% | 6.2% | 7.6% | 6.7% |